Liver resection after Y-90 radioembolization: a systematic review and meta-analysis of perioperative morbidity and mortality

被引:8
作者
Khan, Asama [1 ]
Sayles, Harlan R. [2 ]
Dhir, Mashaal [1 ]
机构
[1] SUNY Upstate Med Univ, Dept Surg, Div Surg Oncol, 750 East Adams St, Syracuse, NY 13210 USA
[2] Univ Nebraska, Dept Biostat, Med Ctr, Coll Publ Hlth, Omaha, NE 68198 USA
关键词
INTERNAL RADIATION-THERAPY; HEPATOCELLULAR-CARCINOMA; CHEMOTHERAPY; SURVIVAL; SAFETY; COMPLICATIONS; MICROSPHERES; RADIOTHERAPY; HEPATECTOMY; METASTASES;
D O I
10.1016/j.hpb.2021.08.948
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Data on morbidity and mortality following liver resection after radioembolization (Y90) are limited and controversial. Therefore, the perioperative morbidity and mortality of liver resections after Y90 treatment were investigated with systematic review and meta-analysis. Methods: A PubMed search was conducted to identify studies of liver resection after previous Y90 treatment. Systematic review and meta-analysis for perioperative morbidity and mortality were perfomed using the 2009 PRISMA guidelines and STATA 16.1 software. Results: A total of 16 studies reporting on 276 patients who underwent liver resection after Y90 met the inclusion criteria and were included in the meta-analysis. Meta-analysis of 30-day mortality rates yielded pooled mortality of 0.5% (95% CI 0.0-3.2%). Six studies (155 patients) reported a pooled 90-day mortality of 3.0% (95% CI 0.3-7.4%). The median time to resection after Y90 ranged from 2 to 12.5 months in various studies. In all studies where the median resection was undertaken eight or more months after Y90, zero 30-day mortality was reported. A meta-analysis of overall grade 3 or higher morbidity noted a rate of 26% (95% CI 16-37%). Conclusions: Liver resection after Y90 may be safe in very well selected patients. Delaying resection after Y90 may further decrease mortality.
引用
收藏
页码:152 / 160
页数:9
相关论文
共 29 条
[1]   Complications after liver surgery: a benchmark analysis [J].
Bagante, Fabio ;
Ruzzenente, Andrea ;
Beal, Eliza W. ;
Campagnaro, Tommaso ;
Merath, Katiuscha ;
Conci, Simone ;
Akgul, Ozgur ;
Alexandrescu, Sorin ;
Marques, Hugo P. ;
Lam, Vincent ;
Shen, Feng ;
Poultsides, George A. ;
Soubrane, Olivier ;
Martel, Guillaume ;
Iacono, Calogero ;
Guglielmi, Alfredo ;
Pawlik, Timothy M. .
HPB, 2019, 21 (09) :1139-1149
[2]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[3]   Hepatectomy after hepatic arterial therapy with either yttrium-90 or drug-eluting bead chemotherapy: is it safe? [J].
Brown, Russell E. ;
Bower, Matthew R. ;
Metzger, Tiffany L. ;
Scoggins, Charles R. ;
McMasters, Kelly M. ;
Hahl, Michael J. ;
Tatum, Cliff ;
Martin, Robert C. G. .
HPB, 2011, 13 (02) :91-95
[4]   Radioembolization and systemic chemotherapy improves response and survival for unresectable colorectal liver metastases [J].
Chua, Terence C. ;
Bester, Lourens ;
Saxena, Akshat ;
Morris, David L. .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (05) :865-873
[5]   Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey [J].
Dindo, D ;
Demartines, N ;
Clavien, PA .
ANNALS OF SURGERY, 2004, 240 (02) :205-213
[6]   Outcomes of Surgical Resection after Radioembolization for Hepatocellular Carcinoma [J].
Gabr, Ahmed ;
Abouchaleh, Nadine ;
Ali, Rehan ;
Baker, Talia ;
Caicedo, Juan ;
Katariya, Nitin ;
Abecassis, Michael ;
Riaz, Ahsun ;
Lewandowski, Robert J. ;
Salem, Riad .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 29 (11) :1502-1510
[7]   Liver Resection for Metastatic Disease After Y90 Radioembolization: A Case Series with Long-Term Follow-Up [J].
Henry, Leonard R. ;
Hostetter, Richard B. ;
Ressler, Brittany ;
Bowser, Ingrid ;
Yan, Min ;
Vaghefi, Houman ;
Abad, John ;
Gulec, Seza ;
Schwarz, Roderich E. .
ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (02) :467-474
[8]   Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma [J].
Inarrairaegui, M. ;
Pardo, F. ;
Bilbao, J. I. ;
Rotellar, F. ;
Benito, A. ;
D'Avola, D. ;
Herrero, J. I. ;
Rodriguez, M. ;
Marti, P. ;
Zozaya, G. ;
Dominguez, I. ;
Quiroga, J. ;
Sangro, B. .
EJSO, 2012, 38 (07) :594-601
[9]   Liver Resection After Selective Internal Radiotherapy (SIRT): Proof of Concept, Initial Survival, and Safety [J].
Justinger, Christoph ;
Kouladouros, Konstantinos ;
Gaertner, Daniel ;
Tatsch, Klaus ;
Reimer, Peter ;
Ruediger, Thomas ;
Binnenhei, Martin ;
Bentz, Martin ;
Schoen, Michael R. .
JOURNAL OF SURGICAL ONCOLOGY, 2015, 112 (04) :436-442
[10]   Yttrium-90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma:: Downstaging to resection, RFA and bridge to transplantation [J].
Kulik, Laura M. ;
Atassi, Bassel ;
Van Holsbeeck, Lodewijk ;
Souman, Tameem ;
Lewandowski, Robert J. ;
Mulcahy, Mary F. ;
Hunter, Russell D. ;
Nemcek, Albert A., Jr. ;
Abecassis, Michael M. ;
Haines, Kenneth G., III ;
Salem, Riad .
JOURNAL OF SURGICAL ONCOLOGY, 2006, 94 (07) :572-586